Meropenem Hikma

Meropenem, the active ingredient in Meropenem Hikma, is a carbapenem presented as a intravenous solution for intravenous use. It treats serious bacterial infections in hospitalized patients, including pneumonia, intra‑abdominal infections, and meningitis.

GNH USA supplies Meropenem Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem Hikma is a broad‑spectrum carbapenem antibiotic used to treat severe infections caused by susceptible bacteria.

- Complicated intra‑abdominal infections: provides bacterial eradication in polymicrobial abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis. - Skin and soft tissue infections: resolves deep tissue infections with gram‑negative and anaerobic organisms. - Community‑acquired and hospital‑acquired pneumonia: treats resistant respiratory pathogens. - Meningitis: penetrates the cerebrospinal fluid to combat bacterial meningitis.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves. - Infusion site reactions: redness or discomfort at the injection site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile‑associated diarrhea: can be life‑threatening. - Hematologic abnormalities: neutropenia, thrombocytopenia, or anemia. - Renal impairment: worsening kidney function in susceptible individuals. - Hepatotoxicity: elevated liver enzymes or jaundice.

Before using Meropenem Hikma, consider the following precautions: - Renal function: adjust dose in patients with impaired renal clearance. - Seizure risk: monitor patients with a history of seizures or CNS disorders. - Allergy: avoid in individuals with known hypersensitivity to carbapenems or β‑lactams. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze, and retain in the original packaging.

Meropenem Hikma may interact with other medicines as follows:

Major Interactions (Avoid): - Valproic acid: increased risk of seizures. - Probenecid: may raise meropenem plasma concentrations. - Cytotoxic agents: potential additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Aminoglycosides: watch for combined nephrotoxic effects. - Anticoagulants (e.g., warfarin): observe coagulation parameters for possible alterations.